 I. Determine whether children with newly diagnosed low- or intermediate-risk extracranial germ cell tumors GCTs can maintain a 3-year event-free survival of at least 92 for intermediate-risk tumors only and overall survival of at least 95 both low-risk and intermediate-risk tumors after treatment with surgery followed by compressed cisplatin, etoposide, and bleomycin low-risk disease closed to accrual as of 012010. 